Clinical Trial

Study Assessing the Contribution of Telemedicine Monitoring in Addition to Standard Follow-up of an Obesity Program

Study acronym: STROBERRY
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
STROBERRY Study is a Prospective, monocentric, randomized, open-label study assessing the contribution of telemedicine, in addition to standard follow-up, strengthening an Obesity program in Berry (France). The principal objective is to study the effectiveness of a follow-up reinforced with telemedicine in addition to the standard multidisciplinary annual follow-up on the rate of patients lost to follow-up after initial or second line management in a multidisciplinary bariatric medical program
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-07-12; most recent amendment 2024-04-23.
Trial Details
NCT Number NCT05954377
Lead Sponsor Elsan
Conditions Obesity
Enrollment 116 participants
Start Date 2024-09
Primary Completion 2030-03 (estimated)
Study Completion 2030-03 (estimated)
Updated on ClinicalTrials.gov 2024-04-24